{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:45:54Z","timestamp":1774529154401,"version":"3.50.1"},"reference-count":21,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. bras. pneumol."],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:p>OBJETIVO: Analisar os desfechos do tratamento da tuberculose e seus preditores. M\u00c9TODOS: Estudo longitudinal de coorte de pacientes com tuberculose tratados entre 2004 e 2006 no Instituto de Pesquisa Evandro Chagas, na cidade do Rio de Janeiro. As raz\u00f5es de risco ajustadas (RRa) dos preditores foram estimadas. RESULTADOS: Foram inclu\u00eddos 311 pacientes. As taxas de cura, de abandono, de mortalidade e de falha terap\u00eautica foram, respectivamente, 72%, 19%, 6% e 2%. A troca de regime terap\u00eautico por eventos adversos foi necess\u00e1ria em 8%. O alcoolismo (RRa, 0,30), uso do regime estreptomicina+etambutol+ofloxacina (SEO; RRa, 0,32), infec\u00e7\u00e3o por HIV sem tratamento antirretroviral (TARV; RRa, 0,36) e o uso do regime rifampicina+isoniazida+pirazinamida+etambutol (RRa, 0,58) reduziram a probabilidade de cura. A faixa et\u00e1ria mais jovem (RRa, 3,84) e o alcoolismo (RRa, 1,76) aumentaram a probabilidade do abandono. N\u00e3o foi poss\u00edvel determinar as RRa para os demais desfechos devido a suas baixas preval\u00eancias. Entretanto, medidas do risco relativo (RR) identificaram os seguintes potenciais preditores do \u00f3bito: uso de esquema SEO (RR, 11,43), infec\u00e7\u00e3o pelo HIV sem TARV (RR, 9,64), forma cl\u00ednica disseminada (RR, 9,09), aus\u00eancia de confirma\u00e7\u00e3o bacteriol\u00f3gica (RR, 4,00), diabetes mellitus (RR, 3,94) e comportamento homo\/bissexual (RR, 2,97). A baixa renda (RR, 11,70) foi potencial preditor para falha terap\u00eautica, ao passo que infec\u00e7\u00e3o pelo HIV com uso de TARV (RR, 2,46) e forma cl\u00ednica disseminada (RR, 3,57) foram potenciais preditores para troca do esquema por evento adverso. CONCLUS\u00d5ES: O esquema SEO deve ser utilizado transitoriamente quando poss\u00edvel. Os dados confirmam a import\u00e2ncia de TARV e sugerem a necessidade de seu in\u00edcio precoce.<\/jats:p>","DOI":"10.1590\/s1806-37132012000100013","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T01:24:30Z","timestamp":1331169870000},"page":"88-97","source":"Crossref","is-referenced-by-count":29,"title":["Preditores dos desfechos do tratamento da tuberculose"],"prefix":"10.1590","volume":"38","author":[{"given":"Renata de Lima","family":"Orofino","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Emmanuel Americano do","family":"Brasil","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anete","family":"Trajman","sequence":"additional","affiliation":[{"name":"Universidade Gama Filho, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina Arana Stanis","family":"Schmaltz","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margareth","family":"Dalcolmo","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ria Cavalcanti","family":"Rolla","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Situa\u00e7\u00e3o da Tuberculose no Brasil","first-page":"33"},{"key":"ref2","series-title":"Tuberculose: guia de vigil\u00e2ncia epidemiol\u00f3gica","year":"2002"},{"issue":"1","key":"ref3","first-page":"S4","article-title":"II Consenso Brasileiro de Tuberculose - Diretrizes Brasileiras para Tuberculose 2004","volume":"30","year":"2004","journal-title":"J Bras Pneumol"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1164\/ajrccm\/146.4.849","article-title":"Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya: Analysis of early (6-month) mortality","volume":"146","author":"Nunn P","year":"1992","journal-title":"Am Rev Respir Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0003-0805","issn-type":"print"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/QAI.0b013e3181b31e56","article-title":"Influence of HIV infection on mortality in a cohort of patients treated for tuberculosis in the context of wide access to HAART, in Rio de Janeiro, Brazil","volume":"52","author":"Schmaltz CA","year":"2009","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"issue":"8","key":"ref6","first-page":"238","article-title":"Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors","volume":"291","year":"2004","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref7","series-title":"Recomenda\u00e7\u00f5es para terapia anti-retroviral em adultos infectados pelo HIV: 2008","year":"2008"},{"key":"ref8","series-title":"Sistema Nacional de Vigil\u00e2ncia em Sa\u00fade: Relat\u00f3rio de Situa\u00e7\u00e3o - Rio de Janeiro","first-page":"25"},{"key":"ref9","first-page":"7","article-title":"Efetividade do esquema 3 (3sSZEEt\/9EEt) no retratamento da tuberculose na rotina das unidades de sa\u00fade","volume":"8","author":"Campos HS","year":"2000","journal-title":"Bol Pneum Sanit"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00002030-199903110-00001","article-title":"The treatment of tuberculosis in HIV-infected persons","volume":"13","author":"Pozniak AL","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg HM","year":"2003","journal-title":"Am J Respir Crit Care Med","ISSN":"https:\/\/id.crossref.org\/issn\/1073-449X","issn-type":"print"},{"issue":"6","key":"ref12","first-page":"368","article-title":"Prognostic factors for pulmonary tuberculosis outcome in Recife, Pernambuco, Brazil [Article in Portuguese]","volume":"9","author":"Albuquerque MF","year":"2001","journal-title":"Rev Panam Salud Publica","ISSN":"https:\/\/id.crossref.org\/issn\/1020-4989","issn-type":"print"},{"key":"ref13","first-page":"10","year":"2011"},{"issue":"7","key":"ref14","first-page":"775","article-title":"Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury","volume":"11","author":"Szklo A","year":"2007","journal-title":"Int J Tuberc Lung Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1027-3719","issn-type":"print"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1590\/S0102-35862000000600004","article-title":"Estudo caso-controle de indicadores de abandono em doentes com tuberculose","volume":"26","author":"Ribeiro SA","year":"2000","journal-title":"J Pneumol","ISSN":"https:\/\/id.crossref.org\/issn\/0102-3586","issn-type":"print"},{"issue":"1","key":"ref16","first-page":"65","article-title":"Modelo de predi\u00e7\u00e3o para o abandono do tratamento da tuberculose pulmonar","volume":"7","author":"Natal S","year":"1999","journal-title":"Bol Pneumol Sanit"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/thx.2006.058867","article-title":"Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection","volume":"61","author":"Breen RA","year":"2006","journal-title":"Thorax","ISSN":"https:\/\/id.crossref.org\/issn\/0040-6376","issn-type":"print"},{"key":"ref18","series-title":"Significant enhancement in survival with early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis: \"34% Reduction in Mortality in Early Arm\""},{"issue":"4","key":"ref19","first-page":"365","article-title":"Tuberculose e diabete melito: 40 casos observados no Hospital Universit\u00e1rio Lauro Wanderley","volume":"8","author":"Leite AA","year":"1999","journal-title":"Pulm\u00e3o RJ"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4269\/ajtmh.2009.80.634","article-title":"Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis","volume":"80","author":"Dooley KE","year":"2009","journal-title":"Am J Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"e14014","DOI":"10.1371\/journal.pone.0014014","article-title":"Patients' costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil","volume":"5","author":"Steffen R","year":"2010","journal-title":"PLoS One"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/jbpneu\/v38n1\/v38n1a13.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T02:09:52Z","timestamp":1561428592000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1806-37132012000100013&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1806-37132012000100013"],"URL":"https:\/\/doi.org\/10.1590\/s1806-37132012000100013","relation":{},"ISSN":["1806-3713"],"issn-type":[{"value":"1806-3713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}